Entries of Vordermark, D. on the publication server

Dapper, H., Belka, C., Bock, F., Budach, V., Budach, W., Christiansen, H., Debus, J., Distel, L., Dunst, J., Eckert, F., Eich, H., Eicheler, W., Engenhart-Cabillic, R., Fietkau, R., Fleischmann, D. F., Frerker, B., Giordano, F. A., Grosu, A. L., Herfarth, K., Hildebrandt, G., Kaul, D., Kölbl, O., Krause, M., Krug, D., Martin, D., Matuschek, C., Medenwald, D., Nicolay, N. H., Niewald, M., Oertel, M., Petersen, C., Pohl, Fabian, Raabe, A., Rödel, C., Rübe, C., Schmalz, C., Schmeel, L. C., Steinmann, D., Stüben, G., Thamm, R., Vordermark, D., Vorwerk, H., Wiegel, T., Zips, D. and Combs, S. E. (2021) Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations. Strahlentherapie und Onkologie 198 (1), pp. 1-11.

Steinmann, D., Vordermark, D., Geinitz, H., Aschoff, R., Bayerl, A., Gerstein, J., Hipp, M., van Oorschot, B., Wypior, H.J. and Schäfer, C. (2013) Proxy assessment of patients before and after radiotherapy for brain metastases. Strahlentherapie und Onkologie 189 (1), pp. 47-53. Fulltext not available.

Dellas, K., Roedel, F., Arnold, D., Kappler, M., Hipp, M., Bataille, F., Vordermark, D., Roedel, C. and Hartmann, A. (2010) EGFR, PTEN, and survivin expression in pre- and posttherapeutic specimens does not predict a clinical benefit from preoperative chemoradiation with cetuximab in patients (pts) with locally advanced rectal cancer (LARC). Journal of Clinical Oncology 28 (15_sup), p. 3653. Fulltext not available.

Vordermark, D., Becker, G., Flentje, M., Richter, S., Goerttler-Krauspe, I. and Koelbl, O. (2000) Transcranial sonography: integration into target volume definition for glioblastoma multiforme. International journal of radiation oncology, biology, physics 47 (3), pp. 565-571. Fulltext not available.